There is disagreement regarding the benefits of goal-directed therapy in moderate-risk abdominal surgery. Therefore, we tested the hypothesis that the addition of non-invasive cardiac index and pulse pressure variation monitoring to mean arterial pressure-based goal-directed therapy would reduce the incidence of postoperative complications in patients having moderate-risk abdominal surgery. In this pragmatic multicentre randomised controlled trial, we randomly allocated 244 patients by envelope drawing in a 1:1 fashion, stratified per centre. All patients had mean arterial pressure, cardiac index and pulse pressure variation measured continuously. In one group, healthcare professionals were blinded to cardiac index and pulse pressure variation values and were asked to guide haemodynamic therapy only based on mean arterial pressure (control group). In the second group, cardiac index and pulse pressure variation values were displayed and kept within target ranges following a pre-defined algorithm (CI-PPV group). The primary endpoint was the incidence of postoperative complications within 30 days. One hundred and seventy-five patients were eligible for final analysis. Overall complication rates were similar (42/94 (44.7%) vs. 38/81 (46.9%) in the control and CI-PPV groups, respectively; p = 0.95). The CI-PPV group had lower mean (SD) pulse pressure variation values (9.5 (2.0)% vs. 11.9 (4.6)%; p = 0.003) and higher mean (SD) 
Introduction
Goal-directed therapy is frequently applied with the intention to optimise peri-operative haemodynamic profiles and maximise oxygen delivery in patients undergoing abdominal surgery [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] . The beneficial effects of goal-directed therapy on outcome have been investigated predominately in patients with a highrisk profile undergoing major procedures [11, 12] . In particular, goal-directed therapy is associated with a lower mortality rate only in high-risk patients, while the beneficial effects in moderate-risk groups have been restricted to reduced complication rates [12] . Moreover, Rollins and Lobo showed that the favourable effects of goal-directed therapy on outcome were only present in settings where patients were not managed within an enhanced recovery after surgery (ERAS) pathway [11] .
Although most of the effects of haemodynamic therapy on outcome have been studied in high-risk patients, evidence for patients with moderate surgical risk profiles is limited. This may be explained by the restricted use of invasive monitoring in moderate-risk surgery. With the availability of non-invasive haemodynamic monitoring devices, a closer evaluation of the effects of volume therapy in patients with a moderate surgical risk becomes possible; however, the available evidence is conflicting. In a pilot study, Joosten et al. proved the feasibility of non-invasive arterial blood pressure-guided fluid administration through a closed-loop system that included the assessment of stroke volume (SV), cardiac index (CI) and dynamic elastance [13] . In another study, volume therapy guided by pulse pressure variation (PPV) in patients undergoing total knee or hip replacement surgery was associated with fewer postoperative complications when compared with a control group [14] . In contrast, in patients undergoing major abdominal surgery, no benefits of mean arterial pressure (MAP) or CI-based haemodynamic guidance could be observed [15] .
It remains unclear whether targeting advanced indices like PPV and CI for haemodynamic optimisation would be of added value to MAP-guided volume therapy in patients undergoing moderate-risk abdominal surgery. In this pragmatic study, we hypothesised that the addition of these two indices to MAP-based volume therapy would reduce the incidence of postoperative complications in patients with a moderate surgical risk profile.
Methods
The COGUIDE randomised, controlled clinical trial was conducted in four tertiary hospitals in the Netherlands between January 2012 and November 2013. Ethical approval was granted at each of the participating centres. All patients gave written informed consent. Patients were followed up for 30 days following surgery.
Patients were eligible for study inclusion if elective moderate-risk abdominal surgery was planned and they were aged 18-85 years. Moderate-risk surgery was defined as patients categorised as grade-2 risk according to the Modified Johns Hopkins Surgical Criteria (moderately to significantly invasive procedure, potential blood loss 500-1500 ml, or moderate risk to patient independent of anaesthesia). We did not study patients with any of the following criteria: pre-existing cardiac arrhythmia; emergency procedure; pre-operative admission to the intensive care unit (ICU); BMI < 20 kg.m À2 or > 40 kg.m
À2
; evidence of cardiac decompensation; aortic valve disease; ejection fraction < 0.3; aortic valve stenosis with valve area < 1.2 cm 2 ; pulmonary arterial pressure > 30 mmHg; and tricuspid annular plane systolic excursion < 18 mm.
The anaesthetic technique was left to the discretion of the attending anaesthetist. Ventilation variables were standardised as: ≥ 8 cmH 2 O positive end-expiratory pressure; ≥ 50% oxygen-air mixture; and tidal volume of ≥ 8 ml.kg À1 lean body mass (as required for pulse pressure variation measurements during mechanical ventilation). Ventilation frequencies were adjusted to maintain normocapnia. All patients had an arterial line inserted for continuous monitoring of MAP. The ccNexfin device (Edwards Lifesciences, Amsterdam, the Netherlands), a non-invasive continuous arterial blood pressure monitor, was used for PPV and CI measurements in all patients, and monitoring was instituted before the induction of anaesthesia. The Nexfin monitor derives a finger arterial blood pressure waveform by optical plethysmography using a blood pressure cuff according to the volume-clamp method.
Pulse pressure variation was defined as the relative variation between the highest (PP max ) and lowest (PP min ) pulse pressure divided by the mean of PP max and PP min . The Nexfin CO-trek algorithm is used to calculate SV and CI based on the arterial blood pressure waveform. A built-in expert system for calibration (Physiocal, BMEYE BV, Amsterdam, The Netherlands) adjusts the cuff to determine a proper volume-clamp set point, while a heart reference system is used to compensate for hydrostatic differences between the heart and finger cuff level.
Patients were allocated to one of the two groups by sealed envelope in a 1:1 fashion, stratified per centre. In one group, the attending anaesthetist was blinded to the PPV/CI values and maintained target MAP values > 70 mmHg (as measured by the Nexfin device) with intravenous fluids of any type, vasopressors and/or inotropes, based on their clinical judgement (control group). In the other group, the anaesthetist was required to keep MAP > 70 mmHg, CI > 2.5 l min
À1
.m À2 and PPV < 12% using a predefined protocol ( Fig. 1 ) (CI-PPV group). The study endpoint was based on a reduction in the overall complication rate in the 30 days following surgery. Pre-defined complications were as follows: delirium; urine tract infection; wound infection; ileus; fascial dehiscence or anastomotic leakage; pneumonia; hypovolemia requiring fluid infusion; hypervolemia; oedema; re-operation; and prolonged mechanical ventilation (> 24 h). Postoperative complications were diagnosed by a combination of high clinical suspicion, radiograph or ultrasound evidence (pneumonia, hypervolemia, anastomotic leakage), or laboratory testing (wound infection, pneumonia, urinary tract infection), according to generally applicable guidelines and as reported by a physician in the patient's medical file. Other outcome parameters included ICU admission rate, length of ICU and hospital stay, re-admission to hospital and 30-day mortality. Moreover, the timing of postoperative defaecation and mobilisation was Figure 1 Schematic representation of the haemodynamic protocol for patients undergoing moderate-risk abdominal surgery using mean arterial pressure-guided volume therapy (control group) and cardiac index and pulse pressure variation-guided volume therapy (CI-PPV group). MAP, mean arterial pressure; PPV, pulse pressure variation; CI, cardiac index. recorded, and patients were asked by a standardised questionnaire and two investigator-initiated phone calls (at postoperative days 7 and 30) whether they had visited a general practitioner in the first 30 days following surgery for surgical procedure-related complaints. All reported complications were verified with the patient.
The sample size calculation was based on the incidence of postoperative complications between the two study groups. The literature reports broad incidence ranges for the occurrence of postoperative complications. For our sample size calculation, we used the overall complication rate of 42% in patients following abdominal surgery, as reported by Thompson et al. [16] . To show a reduction in the overall complication rate to 20% (two-sided test with alpha 0.01 and power 90%), 125 patients per group were required, necessitating a total sample size of 250 patients.
We performed a per-protocol analysis of the data using SPSS 22.0 (IBM, New York, NY, USA). Levene's test for equality of variances was used to evaluate data normality. Between group differences were analysed using a two-way Student's t-test and Mann-Whitney test. A chi-square test was used to test differences in frequencies. A p value < 0.05 was considered statistically significant.
Results
Hospital recruitment rates were as follows: 114 (Westfriesgasthuis Hoorn); 70 (Spaarne Gasthuis Hoofddorp); 40 (VU University Medical Center Amsterdam) and 28 (Medical Center Alkmaar). After exclusions, 94 patients in the control group and 81 patients in the CI-PPV group remained for final analysis (Fig. 2 ). Baseline and surgical characteristics are shown in Table 1 . Patients were well matched at baseline, with only a small difference in age between groups.
There was no difference in the overall complication rate between control and CI-PPV groups (Table 2 ). Three patients in the CI-PPV group, compared with none in the control group, required > 24 h of mechanical ventilation due to fascial dehiscence (n = 1), anastomotic leakage (n = 1) and respiratory insufficiency due to a combination of acute kidney injury, ileus and wound infection (n = 1). However, this difference between groups did not reach statistical significance (p = 0.06). A greater number of patients in the CI-PPV group required re-operation, but again this difference did not reach statistical significance (p = 0.08). Mortality was similar in both groups.
Intra-operative haemodynamic indices are shown in Fig. 3 . While MAP was similar in both groups, mean (SD) PPV was higher in the control group compared with the CI-PPV group (11.9 (4.6)% vs. 9,5 (2.0)%, respectively; p = 0.003). Mean (SD) CI was also lower in the control group when compared with the CI-PPV group (2.53 (0.66) l min
, respectively; p = 0.004). Intraoperative fluid and allogeneic blood product administration is shown in Table 3 . There were no differences in the total infused volume of crystalloids, colloids, packed red blood cells or fresh frozen plasma between groups. Fluid loss, blood loss and urine production were similar in both groups. Fewer patients in the control group received vasopressor or inotropic agents. There were no differences between groups for return of defecation or mobility (Fig. 4) .
Discussion
This pragmatic clinical study demonstrated that the addition of non-invasive CI and PPV monitoring to MAP-based goal-directed therapy did not reduce the incidence of postoperative complications in patients undergoing moderate-risk abdominal surgery.
There is ongoing debate regarding the benefits of goal-directed therapy in patients undergoing abdominal surgery. Several studies suggest an overall reduction in peri-operative morbidity and/or mortality in abdominal surgery when a goal-directed approach is used [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] , although the precise effects remain unclear and conclusions are conflicting. Some studies report only slight improvements in secondary endpoints such as postoperative wound infections [5] , hospital length of stay [17] or gastrointestinal recovery [18] . In addition, most benefits of goal-directed therapy were predominantly reported in high-risk populations undergoing abdominal surgery [11, 12] . In particular, the reduction in postoperative morbidity was most pronounced in patients with a high estimated risk for postoperative complications [12] . In contrast, Ramsingh et al. showed outcome improvement after goal-directed haemodynamic management during major abdominal surgery for patients with a low-to moderate-risk profile [18] . Several other studies, however, were unable to demonstrate a similar benefit for this intervention [15, [19] [20] [21] . When reviewing our results in light of these previous studies, the absence of a reduction in complications in the CI-PPV group may be explained by the selection of moderaterisk surgical patients. Moreover, the maintenance of relatively high MAP levels may also have contributed to the lack of effect with CI-PPV-guided goal-directed therapy. Our MAP target was slightly higher than that seen in other studies that have used protocolised target MAP values of ≥ 60 mmHg 7 or ≥ 65 mmHg [6, 8, 9, 15] . Only Donati et al. chose a higher target, with a target MAP value > 80 mmHg [3] . In general, fluid management outside goal-directed therapy interventions varies between individual healthcare providers [22] . It has been suggested that one of the reasons for the outcome improvement associated with goal-directed therapy might be the reduction in fluid load and individualised vasopressor and/or inotropic therapy that is seen when a pre-defined protocol is used. Although we found no differences in total fluid volume administered between groups, fluid infusion rates and vasopressor and inotropic therapy was higher in the CI-PPV group. In line with our findings, the majority of other studies have reported no differences in total fluid volume load when goal-directed therapy is compared with standard practice [6-8, 19, 20, 23-25] . Of note, the fluid load reported in the present study is at the lower end of the spectrum of that reported previously. Other studies have demonstrated improved outcomes, despite giving much larger volumes of peri-operative fluids. The optimal amount of intravenous fluid that should be administered using BMI, body mass index; COPD, chronic obstructive pulmonary disease; ATII, angiotensin-2; ACE, angiotensin-converting enzyme. [3, 15] , others have reported no differences in vasopressor [6-8, 19, 23, 25] or inotropic therapy [7, 19, 23, 25] . The CI-PPV group in our study received more dobutamine and noradrenaline than the control group, while phenylephrine was widely used in the control group, as this is standard practice in the participating hospitals. Since phenylephrine was widely used in the control group, a clear-cut comparison in amount of vasopressors between groups is difficult to make. The use of dobutamine leading to badrenergic-mediated vasodilation theoretically explains the higher use of vasopressors in the CI-PPV group.
The majority of studies regarding postoperative complications requiring ICU admission reported no differences among groups [2, 3, 7, 8, 15, 19, 23, 25] or favoured the use of goal-directed therapy [9, 10] . Challand et al. reported a higher proportion of patients who received goal-directed therapy that had to be admitted to ICU in the postoperative period, but their study lacked an explanation for this remarkable finding [20] . In our study, four patients underwent mechanical ventilation for > 24 h postoperatively. However, the most likely explanation for our finding is the relatively small sample size in our study.
This study was characterised by its pragmatic approach and adherence to clinical variability, which additionally implies that the study has specific limitations. First, there were a small number of patients showing CI levels that were slightly lower than the study target. Second, the attending anaesthetist recorded postoperative complications, which may have influenced data recording. Third, for some of the recorded 'soft' complications, such as hypo-or hypervolemia, there are no clear definitions or diagnostic tools available, which limit the objectivity of this assessment. In our study, CI and PPV monitoring was limited to the intra-operative period; however, postoperative factors may also determine complication rate. Because the benefits of a chain of care are only as strong as the weakest link, the effects of postoperative management strategies may have influenced the incidence of complications. Our data do not allow conclusions about the role of CI and PPV monitoring in the postoperative period. Fourth, the variable use and extent of, enhanced recovery programmes is a drawback seen when recruiting from different centres. Dedication to an enhanced recovery programme was not an inclusion criterion. Finally, in retrospect, the power analysis based on the expected complication reduction was probably overly optimistic, possibly leading to lower recruitment of participants than was necessary. In addition, due to dropouts, the original recruitment targets were not reached in this study. Both these factors may mean that the study was underpowered for the primary outcome measure. Pulse pressure variation and CI were measured with the Nexfin monitor, which is validated in different peri-operative populations, but can be less accurate, especially under circumstances when it matters the most (i.e. low cardiac output states) [26] . The Nexfin failure rate in our study was 6%, which contributed to the decision to perform per-protocol instead of intention-to-treat analyses. Moreover, we used pre-defined target values of haemodynamic indices, and it might be questioned whether these target values can be applied to all patients for moderate- Figure 4 Cumulative proportion of patients with returned defaecation during the postoperative period (a), and the relative number of patients with return of mobility after two postoperative days (b), after moderate-risk abdominal surgery using mean arterial pressure-guided volume therapy (control group; white bars) and cardiac index and pulse pressure variation-guided volume therapy (CI-PPV group; black bars). risk abdominal surgery or whether different values should have been applied for laparoscopic and open surgical procedures. Although PPV is considered to be unaffected by pneumoperitoneum in rabbits [27] , SVV may be affected by increasing intra-abdominal pressure in a laparoscopic cholecystectomy setting [28] . Renner et al. assessed in a porcine model if PPV and SVV were able to predict fluid responsiveness during pneumoperitoneum, and found PPV to be preserved in detecting fluid responsiveness, although with an increased cut-off value to over 20% [29] . Hoiseth et al.
showed that both SVV and PPV are influenced by pneumoperitoneum [30] . Because PPV seems more accurate than SVV under different intra-abdominal pressures [31] , we targeted therapy during pneumoperitoneum based on PPV values. In a previous study, we showed that the addition of PPV/CI-guided volume therapy to a MAP-based haemodynamic protocol had no benefit on tissue perfusion at a microcirculatory level [32] . From this COGUIDE study, we found no evidence of a reduction in the overall postoperative complication rate when PPV and CI were added as haemodynamic indices to a fixed MAP-guided volume strategy in a moderate-risk abdominal surgical population. This conclusion is in line with the recent review and meta-analysis of Voldby et al., stating that only a selection of the surgical population will benefit from a goal-directed approach, in particular, those patients with a high risk profile [33] . For non-high-risk profile patients undergoing uncomplicated surgical procedures, it would probably be sufficient to achieve an intra-operative zero fluid balance [34] . Our findings emphasise that one protocol may not fit all, and more emphasis on physiological, rather than protocol-based haemodynamic monitoring and treatment strategies, is warranted.
